Cargando…
Propagating Relationship of Cerebral Oximetric Volume and the Clinical Outcome of Recombinant Tissue Plasminogen Activator (r-TPA) Therapy on Acute Cerebral Ischemic Stroke Patients
INTRODUCTION: Currently, the most available treatment for acute ischemic stroke (AIS) is thrombolytic therapy with recombinant tissue plasminogen activator (r-TPA). A challenge in r-TPA therapy is the prediction of recovery in each case. OBJECTIVE: The aim was to find a possible relationship between...
Autores principales: | Paybast, Sepideh, Ashraf, Ali, Sarshad, Hakimeh, Shakiba, Maryam, Moadabi, Yasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955029/ https://www.ncbi.nlm.nih.gov/pubmed/31938776 http://dx.doi.org/10.22114/ajem.v0i0.174 |
Ejemplares similares
-
Hypocapnia Attenuates, and Nitrous Oxide Disturbs the Cerebral Oximetric Response to the Rapid Introduction of Desflurane
por: Lee, Younsuk, et al.
Publicado: (2009) -
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014) -
Tissue-type Plasminogen Activator (tPA) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate
por: Jeanneret, Valerie, et al.
Publicado: (2016) -
Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents
por: Sczepanski, Matthew, et al.
Publicado: (2018) -
The Various Oximetric Techniques Used for the Evaluation of Blood Oxygenation
por: Nitzan, Meir, et al.
Publicado: (2020)